NDC 50509-100-01 - Sodium Bicarbonate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50509-100
- Requested NDC
- 50509-100-01
- Package NDCs from labels
- 50509-100-01, 50509-100-02, 50509-100-03, 50509-100-04
- Manufacturer
- Onpharma, Inc. | WuXi AppTec, Inc. | Avrio Biopharmaceuticals, LLC | Alliance Medical Products, Inc
- Effective date
- 2014-01-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sodium Bicarbonate | Onpharma, Inc. | WuXi AppTec, Inc. | Avrio Biopharmaceuticals, LLC | Alliance Medical Products, Inc | 2014-01-31 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50509-100-02 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-48d2-60a7-e053-dbdaa90a05bd | SODIUM BICARBONATE INJ., 8.4% USP NEUTRALIZING ADDITIVE SOLUTION Rx only Volume 2.7 mL per cartridge 2.7 mEq (1mEq/mL) Volume 1.7 mL per cartridge 1.7 mEq (1mEq/mL) |
| 50509-100-04 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-48d2-60a7-e053-dbdaa90a05bd | SODIUM BICARBONATE INJ., 8.4% USP NEUTRALIZING ADDITIVE SOLUTION Rx only Volume 2.7 mL per cartridge 2.7 mEq (1mEq/mL) Volume 1.7 mL per cartridge 1.7 mEq (1mEq/mL) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50509-100-01 | Sodium Bicarbonate | 2.7 mL in 1 CARTRIDGE | SOLUTION | 2.7 | 19 | |
| 50509-100-02 | Sodium Bicarbonate | 4 in 1 CARTON | SOLUTION | 4 | 19 | |
| 50509-100-03 | Sodium Bicarbonate | 1.7 mL in 1 CARTRIDGE | SOLUTION | 1.7 | 19 | |
| 50509-100-04 | Sodium Bicarbonate | 4 in 1 CARTON | SOLUTION | 4 | 19 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| SODIUM BICARBONATE | ACTIVE INGREDIENT | 8MDF5V39QO | SODIUM BICARBONATE SOLUTION [ONPHARMA, INC.] | 19 | |
| BICARBONATE ION | ACTIVE MOIETY | HN1ZRA3Q20 | SODIUM BICARBONATE SOLUTION [ONPHARMA, INC.] | 19 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stomachin Antacid | MAGNESIUM CARBONATE AND SODIUM BICARBONATE | Chang Kuo Chou Pharmaceutical Co., Ltd. | 60fa0650-8785-4cb3-8f88-1a437296252f | 2026-11-02 | Warnings | 8MDF5V39QO |
| Arm and Hammer Baking Soda | SODIUM BICARBONATE | Church & Dwight Co., Inc. | 643fe204-4a7b-00e4-e053-2a91aa0aef06 | 2026-10-28 | Warnings | 8MDF5V39QO |
| Zegerid OTC | OMEPRAOLE, SODIUM BICARBONATE | Riley Consumer Care LLC | 8d00c19a-d86b-4a2f-8791-b320ad3ca781 | 2026-10-26 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate 10 gr | SODIUM BICARBONATE | GRAXCELL PHARMACEUTICAL, LLC | 897dbb09-fb47-4e03-8cae-bf76d48a7a03 | 2026-10-26 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Rugby Laboratories | e73b5871-4a87-4473-ab00-5e5395be017d | 2026-10-16 | Warnings | 8MDF5V39QO |
| After Bite Advanced | SODIUM BICARBONATE | Tender Corporation d/b/a Adventure Ready Brands | 223d1de8-7940-bbdc-e063-6294a90a51d8 | 2026-10-16 | Warnings | 8MDF5V39QO |
| QUABIC-100 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | 1484a825-40c6-a9c9-e063-6294a90a9ca4 | 2026-10-16 | Warnings | 8MDF5V39QO |
| QUABIC-300 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | c3cd7f0f-8d70-23af-e053-2a95a90a569b | 2026-10-16 | Warnings | 8MDF5V39QO |
| QUABIC-100 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | 28152c9f-b15c-3707-e063-6394a90a70e9 | 2026-10-16 | Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Sun Pharmaceutical Industries, Inc. | 5ae65432-04a1-4b6b-8536-2535064fc782 | 2026-10-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| Good Sense Omeprazole and Sodium Bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | L. Perrigo Company | bcf32242-de17-4da1-b707-4ce26262eb78 | 2026-10-14 | Warnings | 8MDF5V39QO |
| Sal De Uvas Picot | CITRIC ACID MONOHYDRATE, SODIUM BICARBONATE | Navajo Manufacturing Company Inc. | ff6ac79d-564d-4abf-83c7-b01751249c7f | 2026-10-09 | Warnings | 8MDF5V39QO |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sal de Uvas Picot | CITRIC ACID MONOHYDRATE AND SODIUM BICARBONATE | Navajo Manufacturing Company Inc. | 5d6d297d-770b-dd9f-e063-6294a90a4bb8 | 2026-10-02 | Warnings | 8MDF5V39QO |
| Omeprazole/Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Westminster Pharmaceuticals, LLC | d69c2f0f-4e8b-422a-8aaf-a825998b04e0 | 2026-09-25 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Major Pharmaceuticals | ebf340c9-0b6d-13d2-e053-2995a90ae338 | 2026-09-24 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Rugby Laboratories | 28cdf049-acdb-4098-a5ca-e86257c81954 | 2026-09-24 | Warnings | 8MDF5V39QO |
| OMEPRAZOLE AND SODIUM BICARBONATE | OMEPRAZOLE AND SODIUM BICARBONATE | Aurohealth LLC | 224fe1a6-84e4-41eb-a328-1349f687f7f3 | 2026-09-22 | Warnings | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.